These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1069 related items for PubMed ID: 26276068

  • 1. Hospital-based and telemonitoring guided home-based training programs: effects on exercise tolerance and quality of life in patients with heart failure (NYHA class III) and cardiac resynchronization therapy. A randomized, prospective observation.
    Smolis-Bąk E, Dąbrowski R, Piotrowicz E, Chwyczko T, Dobraszkiewicz-Wasilewska B, Kowalik I, Kazimierska B, Jędrzejczyk B, Smolis R, Gepner K, Maciąg A, Sterliński M, Szwed H.
    Int J Cardiol; 2015 Nov 15; 199():442-7. PubMed ID: 26276068
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial.
    Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B, Canby RC, Schroeder JS, Liem LB, Hall S, Wheelan K, Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators.
    JAMA; 2003 May 28; 289(20):2685-94. PubMed ID: 12771115
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Exercise training program in patients with NYHA III class systolic heart failure - Parallel comparison to the effects of resynchronization therapy.
    Smolis-Bąk E, Chwyczko T, Kowalik I, Borowiec A, Maciąg A, Szwed H, Dąbrowski R.
    Adv Med Sci; 2019 Sep 28; 64(2):241-245. PubMed ID: 30822631
    [Abstract] [Full Text] [Related]

  • 8. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
    Linde C, Gold MR, Abraham WT, St John Sutton M, Ghio S, Cerkvenik J, Daubert C, REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction Study Group.
    Eur Heart J; 2013 Sep 28; 34(33):2592-9. PubMed ID: 23641006
    [Abstract] [Full Text] [Related]

  • 9. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure.
    Abraham WT, Young JB, León AR, Adler S, Bank AJ, Hall SA, Lieberman R, Liem LB, O'Connell JB, Schroeder JS, Wheelan KR, Multicenter InSync ICD II Study Group.
    Circulation; 2004 Nov 02; 110(18):2864-8. PubMed ID: 15505095
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of cardiac resynchronization therapy-defibrillator implantation on health status in patients with mild versus moderate symptoms of heart failure.
    Versteeg H, van den Broek KC, Theuns DA, Mommersteeg PM, Alings M, van der Voort PH, Jordaens L, Pedersen SS.
    Am J Cardiol; 2011 Oct 15; 108(8):1155-9. PubMed ID: 21821227
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Implantation feasibility, procedure-related adverse events and lead performance during 1-year follow-up in patients undergoing triple-site cardiac resynchronization therapy: a substudy of TRUST CRT randomized trial.
    Lenarczyk R, Kowalski O, Sredniawa B, Pruszkowska-Skrzep P, Mazurek M, Jędrzejczyk-Patej E, Woźniak A, Pluta S, Głowacki J, Kalarus Z.
    J Cardiovasc Electrophysiol; 2012 Nov 15; 23(11):1228-36. PubMed ID: 22651239
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Impact of cardiac resynchronisation therapy on adaptation of circulatory and respiratory systems to exercise assessed by cardiopulmonary exercise test in patients with chronic heart failure.
    Chwyczko T, Sterliński M, Maciag A, Firek B, Labecka A, Jankowska A, Kośmicki M, Kowalik I, Malczewska B, Szwed H.
    Kardiol Pol; 2008 Apr 15; 66(4):406-12; discussion 413-4. PubMed ID: 18473269
    [Abstract] [Full Text] [Related]

  • 16. High intensity interval training after cardiac resynchronization therapy: An explorative randomized controlled trial.
    Spee RF, Niemeijer VM, Schoots T, Tuinenburg A, Houthuizen P, Wijn PF, Doevendans PA, Kemps HM.
    Int J Cardiol; 2020 Jan 15; 299():169-174. PubMed ID: 31353158
    [Abstract] [Full Text] [Related]

  • 17. Cost-effectiveness of cardiac resynchronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (Resynchronization Reverses remodeling in Systolic Left Ventricular Dysfunction).
    Linde C, Mealing S, Hawkins N, Eaton J, Brown B, Daubert JC, REVERSE study group.
    Eur Heart J; 2011 Jul 15; 32(13):1631-9. PubMed ID: 21112898
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.